Literature DB >> 6191852

Intensive combination chemotherapy for cancer of the oral cavity.

N N Khanna, P K Srivastava, S Khanna, S N Das.   

Abstract

Thirty advanced cases of cancer of the oral cavity were treated by intensive combination chemotherapy using bleomycin, methotrexate, 5-fluorouracil, cyclophosphamide, and Oncovin administered over a period of 48 hours. Bleomycin was given as a continuous infusion and Oncovin was administered six hours prior to the administration of other drugs. A clinical response was obtained in 73.3% of the cases, a complete response in 33.3%, and a partial response in 40%. The toxicity was within acceptable limits.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191852     DOI: 10.1002/1097-0142(19830901)52:5<790::aid-cncr2820520506>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Circulating cycloxygenase-2 in patients with tobacco-related intraoral squamous cell carcinoma and evaluation of its peptide inhibitors as potential antitumor agent.

Authors:  Vaishali Kapoor; Abhay K Singh; Sharmistha Dey; Suresh C Sharma; Satya N Das
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

2.  Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma.

Authors:  Satya N Das; Pratima Khare; Manoj K Singh; Suresh C Sharma
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

3.  Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.

Authors:  Satya N Das; Pratima Khare; Manoj K Singh; Suresh C Sharma
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375

4.  Circulating Vimentin Over-Expression in Patients with Oral Sub Mucosal Fibrosis and Oral Squamous Cell Carcinoma.

Authors:  Sadhna Aggarwal; Baldeep Singh; Suresh C Sharma; Satya N Das
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2022-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.